Literature DB >> 12681374

Mechanisms involved in the pressor response to noradrenaline injection into the cingulate cortex of unanesthetized rats.

K B P Fernandes1, G E Crippa, R F Tavares, J Antunes-Rodrigues, F M A Corrêa.   

Abstract

The cingulate cortex (CC) is involved in cardiovascular modulation. CC electrical or chemical stimulation may evoke either pressor or depressor responses, depending on the stimulated site and experimental conditions such as anesthesia. Noradrenaline (NA) is involved in cardiovascular regulation and it is present throughout the cortex. However, there is no report on the cardiovascular effects of intracortical injections of NA. We attempted to verify the effect of NA injection into the CC and to identify possible receptor and peripheral mechanisms involved. NA injection caused pressor responses accompanied by bradycardia, in unanesthetized rats. These responses were markedly reduced under urethane anesthesia. The pressor response was blocked by intracortical pretreatment with phenoxybenzamine or the selective alpha(1)-antagonist WB4101, and it was not affected by pretreatment with the selective alpha(2)-antagonist RX821002, suggesting that alpha(1)-adrenoceptors mediate the response. The pressor response was potentiated by pretreatment with the ganglion blocker mecamylamine and it was abolished by pretreatment with the vasopressin antagonist, dTyr(CH(2)) (5)(Me)AVP or by hypophysectomy. Circulating vasopressin levels were increased after NA injection into the CC. The present results indicate that the pressor response to local injection of NA within the CC is independent of sympathetic nerve activation and is mediated by vasopressin release.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681374     DOI: 10.1016/s0028-3908(03)00067-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Respiratory, metabolic and cardiac functions are altered by disinhibition of subregions of the medial prefrontal cortex.

Authors:  Sarah F Hassan; Jennifer L Cornish; Ann K Goodchild
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

2.  Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system.

Authors:  Annette D de Kloet; Lei Wang; Jacob A Ludin; Justin A Smith; David J Pioquinto; Helmut Hiller; U Muscha Steckelings; Deborah A Scheuer; Colin Sumners; Eric G Krause
Journal:  Brain Struct Funct       Date:  2014-11-27       Impact factor: 3.270

3.  Brain pathways involved in the modulatory effects of noradrenaline in lateral septal area on cardiovascular responses.

Authors:  América A Scopinho; Daniele C Aguiar; Leonardo B M Resstel; Francisco S Guimarães; Fernando M A Corrêa
Journal:  Cell Mol Neurobiol       Date:  2012-04-07       Impact factor: 5.046

4.  Both alpha1 and alpha2-adrenoceptors mediate the cardiovascular responses to noradrenaline microinjected into the bed nucleus of the stria terminal of rats.

Authors:  C C Crestani; F H F Alves; L B Resstel; F M A Corrêa
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

5.  Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model.

Authors:  Nicola Palomero-Gallagher; Brent A Vogt; Axel Schleicher; Helen S Mayberg; Karl Zilles
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

6.  Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: a review.

Authors:  Carlos C Crestani; Fernando Hf Alves; Felipe V Gomes; Leonardo Bm Resstel; Fernando Ma Correa; James P Herman
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 7.  Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.

Authors:  Carlos Manuel Zapata-Martín Del Campo; Martín Martínez-Rosas; Verónica Guarner-Lans
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.